Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Fish Shellfish Immunol ; 71: 202-209, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29017942

ABSTRACT

Host defense peptides (HDPs), a class of conserved components of animal innate immune system, possess direct antimicrobial activities against invading pathogens and broadly participate in boosting and modulating host immune responses. Cathelicidins is an important family of HDPs that has been identified exclusively in vertebrates. Considering the relatively conserved innate immune system between invertebrates and vertebrates, it is speculated that HDPs from vertebrates may also possess modulating functions on invertebrate innate immune system. In the present study, two novel cathelicidins (As-CATH4 and 5), which had been identified from the Chinese alligator in our previous study, were employed to investigate their functions as novel peptide immunostimulants in Chinese mitten crab. As-CATH4 and 5 exhibited potent, broad-spectrum, and rapid antimicrobial activities against all the tested aquatic pathogenic bacteria. Unlike traditional antibiotics, they target on bacterial cell membrane, induce membrane permeabilization and cell disruption, and ultimately result in cell death. The antimicrobial effect is far more rapid than traditional antibiotics. Therefore they are unlikely to induce bacteria resistance. After the crabs were administered with As-CATH4 and 5, the activities of lysozyme, acid phosphatase and alkaline phosphatase were significantly enhanced, which indicated that the immune system of crabs could be activated by As-CATH4 and 5. In bacteria challenge test, As-CATH4 and 5 could significantly decrease the bacterial numbers in crabs, and increase the survival rates of crabs in both pre-stimulation and co-stimulation groups. All of the results above indicated the great potential of As-CATH4 and 5 as novel peptide immunostimulants in the crab aquaculture.


Subject(s)
Adjuvants, Immunologic/pharmacology , Bacterial Physiological Phenomena/drug effects , Brachyura/immunology , Cathelicidins/immunology , Immunity, Innate , Reptilian Proteins/immunology , Adjuvants, Immunologic/administration & dosage , Alligators and Crocodiles/genetics , Animals , Brachyura/microbiology , Cathelicidins/administration & dosage , Cathelicidins/chemical synthesis , Dose-Response Relationship, Drug , Gene Expression Profiling , Random Allocation , Reptilian Proteins/administration & dosage , Reptilian Proteins/chemical synthesis
2.
Int J Mol Sci ; 17(11)2016 Nov 22.
Article in English | MEDLINE | ID: mdl-27879679

ABSTRACT

Tumor necrosis factor (TNF)-α is a pleiotropic cytokine with intense pro-inflammatory and immunomodulatory properties, and anti-TNF-α biologics are effective therapies for various inflammatory diseases such as inflammatory bowel disease (IBD) and sepsis. Snake venom, as a traditional Chinese medicine, has been used in the treatment of inflammatory diseases in China for centuries. In this research, we constructed a venom gland T7 phage display library of the sea snake Hydrophis cyanocinctus to screen bioactive compounds that antagonize TNF-α and identified a novel nine-amino-acid peptide, termed hydrostatin-TL1 (H-TL1). In enzyme-linked immunosorbent assay (ELISA) and surface plasmon resonance (SPR) analyses, H-TL1 inhibited the interaction between TNF-α and TNF receptor 1 (TNFR1). Further, H-TL1 attenuated the cytotoxicity of TNF-α in L929 cells as determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. H-TL1 also decreased the mRNA expression of TNF-α/TNFR1 downstream targets and suppressed the phosphorylation of well-characterized proteins of downstream signal transduction pathways in HEK-293 cells. In vivo data demonstrated that H-TL1 protects animals against dextran sodium sulfate (DSS)-induced acute colitis and lipopolysaccharide (LPS)-induced acute shock. Given its significant anti-inflammatory activity in vitro and in vivo, H-TL1 is a potential peptide for the development of new agents to treat TNF-α-associated inflammatory diseases.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Colitis/drug therapy , Elapid Venoms/pharmacology , Oligopeptides/pharmacology , Receptors, Tumor Necrosis Factor, Type I/antagonists & inhibitors , Reptilian Proteins/pharmacology , Shock, Septic/drug therapy , Snake Venoms/chemistry , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Acute Disease , Animals , Anti-Inflammatory Agents/chemical synthesis , Anti-Inflammatory Agents/isolation & purification , Cell Line , Cell Survival/drug effects , Colitis/chemically induced , Colitis/genetics , Colitis/pathology , Colubridae/metabolism , Dextran Sulfate , Elapid Venoms/chemical synthesis , Elapid Venoms/isolation & purification , Extracellular Signal-Regulated MAP Kinases/chemistry , Extracellular Signal-Regulated MAP Kinases/genetics , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Gene Expression Regulation , HEK293 Cells , Humans , Lipopolysaccharides , Mice , Oligopeptides/chemical synthesis , Oligopeptides/isolation & purification , Peptide Library , Phosphorylation , Receptors, Tumor Necrosis Factor, Type I/chemistry , Receptors, Tumor Necrosis Factor, Type I/genetics , Reptilian Proteins/chemical synthesis , Reptilian Proteins/isolation & purification , Shock, Septic/chemically induced , Shock, Septic/genetics , Shock, Septic/pathology , Signal Transduction , Snake Venoms/isolation & purification , Transcription, Genetic , Tumor Necrosis Factor-alpha/chemistry , Tumor Necrosis Factor-alpha/genetics , p38 Mitogen-Activated Protein Kinases/chemistry , p38 Mitogen-Activated Protein Kinases/genetics
3.
Biopolymers ; 106(5): 737-45, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27271997

ABSTRACT

Tert-butyloxycarbonyl (t-Boc)-based native chemical ligation (NCL) techniques commonly employ hydrogen fluoride (HF) to create the thioester fragment required for the ligation process. Our research aimed to assess the replacement of HF with Trifluoromethanesulfonic acid (TFMSA). Here we examined a 33 amino acid test peptide, Huwentoxin-I (HwTx-I) as a novel candidate for our TFMSA cleavage protocol. Structurally HwTx-I has an X-Cys(16) -Cys(17) -X sequence mid-region, which makes it an ideal candidate for NCL. Experiments determined that the best yields (16.8%) obtained for 50 mg of a thioester support resin were achieved with a TFMSA volume of 100 µL with a 0.5-h incubation on ice, followed by 2.0 h at room temperature. RP-HPLC/UV and mass spectra indicated the appropriate parent mass and retention of the cleaved HwTx-I N-terminal thioester fragment (Ala(1) -Cys(16) ), which was used in preparation for NCL. The resulting chemically ligated HwTx-I was oxidized/folded, purified, and then assessed for pharmacological target selectivity. Native-like HwTx-I produced by this method yielded an EC50 value of 340.5 ± 26.8 nM for Nav 1.2 and an EC50 value of 504.1 ± 81.3 nM for Nav 1.3, this being similar to previous literature results using native material. This article represents the first NCL based synthesis of this potent sodium channel blocker. Our illustrated approach removes potential restrictions in the advancement of NCL as a common peptide laboratory technique with minimal investment, and removes the hazards associated with HF usage. © 2016 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 106: 737-745, 2016.


Subject(s)
Chemistry Techniques, Synthetic/methods , Mesylates/chemistry , Reptilian Proteins/chemical synthesis , Spider Venoms/chemical synthesis , Reptilian Proteins/chemistry , Spider Venoms/chemistry
4.
Peptides ; 34(1): 19-25, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22094230

ABSTRACT

Huwentoxin-I (HWTX-I) is a 33-residue peptide isolated from the venom of Ornithoctonus huwena and could inhibit TTX-sensitive voltage-gated sodium channels and N-type calcium channels in mammalian dorsal root ganglion (DRG) neurons. However, the effects of HWTX-I on mammalian central neuronal and insect sodium channel subtypes remain unknown. In this study, we found that HWTX-I potently inhibited sodium channels in rat hippocampal and cockroach dorsal unpaired median (DUM) neurons with the IC(50) values of 66.1±5.2 and 4.80±0.58nM, respectively. Taken together with our previous work on DRG neurons (IC(50)≈55nM), the order of sodium channel sensitivity to HWTX-I inhibition was insect central DUM≫mammalian peripheral>mammalian central neurons. HWTX-I exhibited no effect on the steady-state activation and inactivation of sodium channels in rat hippocampal and cockroach DUM neurons.


Subject(s)
Cockroaches/cytology , Ganglia, Spinal/cytology , Hippocampus/metabolism , Neurons/metabolism , Reptilian Proteins/pharmacology , Sodium Channels/metabolism , Spider Venoms/pharmacology , Animals , Cells, Cultured , Electrophysiology , Female , Hippocampus/drug effects , Male , Neurons/drug effects , Rats , Reptilian Proteins/chemical synthesis , Spider Venoms/chemical synthesis
5.
Peptides ; 31(8): 1488-93, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20576537

ABSTRACT

King cobra cathelicidin (OH-CATH) is composed of 34 amino acid residues having strong antibacterial and very weak hemolytic activities as reported by us recently. OH-CATH can be served as a valuable template to develop novel therapeutic drugs. In this study, OH-CATH and six of its analogs were synthesized to explore their structure-function relationships based on their bactericidal and hemolytic activities. Experimental results of OH-CATH(3-34) and OH-CATH(5-34) indicated that the N-terminal 4 amino acid residues of OH-CATH played an important role on its hemolytic activity but had weak effects on its bactericidal activity. Among OH-CATH and its analogs, OH-CATH(5-34) had the lowest hemolytic activity while maintained strong antimicrobial activity. To evaluate its potential usage, the biological activities of OH-CATH(5-34) were compared with those of pexiganan. The bactericidal activity of OH-CATH(5-34) against 5 different species (11 laboratory strains) was 2-4 times stronger than that of pexiganan (4-16 microg/ml vs 8-32 microg/ml). Hemolytic activity of OH-CATH(5-34) against human erythrocytes was 0.69% while that of pexiganan was 16.5% at the dosage of 200 microg/ml. OH-CATH(5-34) showed very weak cytotoxic activities against primary rabbit ventricular endothelial cells and four human cancer cell lines whereas pexiganan showed strong cytotoxic activity against these five cell lines (IC(50)=20-90 microg/ml). The intravenous LD(50) value of OH-CATH(5-34) on mice was 7-fold higher than that of pexiganan (175 mg/kg vs 25mg/kg). Taken together, our results suggested that OH-CATH(5-34) should be considered as an excellent candidate for developing therapeutic drugs.


Subject(s)
Cathelicidins/chemistry , Cathelicidins/pharmacology , Elapidae/metabolism , Peptide Fragments/chemistry , Peptide Fragments/pharmacology , Reptilian Proteins/chemistry , Reptilian Proteins/pharmacology , Animals , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Antimicrobial Cationic Peptides/pharmacology , Antimicrobial Cationic Peptides/therapeutic use , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Cathelicidins/chemical synthesis , Cathelicidins/therapeutic use , Cell Line, Tumor , Cells, Cultured , Drug Design , Endothelial Cells/drug effects , Gram-Negative Bacteria/drug effects , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/drug effects , Gram-Positive Bacteria/isolation & purification , Heart Ventricles/cytology , Heart Ventricles/drug effects , Hemolysis/drug effects , Humans , Lethal Dose 50 , Male , Mice , Microbial Sensitivity Tests , Peptide Fragments/chemical synthesis , Peptide Fragments/therapeutic use , Rabbits , Reptilian Proteins/chemical synthesis , Reptilian Proteins/therapeutic use , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...